- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02556697
In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients (MiPECSE)
Systemic sclerosis (SSc) is a generalized disorder of connective tissue, arterioles and microvessels, characterized by the occurrence of fibrosis and vascular obliteration phenomena. The alterations in lung microvessels are found in pulmonary involvement of scleroderma, which are the most serious complications of the disease.
In pulmonary emphysema, there are also changes in pulmonary microvasculature, which are involved in the onset and development of the disease.
The confocal endomicroscopy is an endoscopic technique which can be performed during a bronchoscopy. This technique makes it possible to observe in real time the most distal pulmonary elements at the microscopic scale. After injection of fluorescein, then the technique of observing the pulmonary microvasculature, in vivo and in situ.
The characterization of microvascular lesions in these two pathologies could improve understanding of their mechanisms and ultimately improve the early management of patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rouen, France, 76031
- Rouen University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with scleroderma with diffuse interstitial pneumonia, indicating a bronchoscopy.
- Patients with pulmonary emphysema indication for bronchoscopy.
- Age greater than 18 years.
- Having an affiliation to social security.
- Signed informed consent.
Exclusion Criteria:
- Severe chronic respiratory insufficiency against-indicating the completion of a bronchoscopy
- Hypercapnia defined by a PaCO2 ≥ 6 kPa
- Disorders of hemostasis against-indicating performing a bronchoscopy
- Anticoagulant therapy can not be interrupted time of completion of the examination
- A history of pneumonectomy or contralateral exploration in a nonfunctional lung
- Contraindication to the injection of fluorescein (including treatment with beta-blocker eye drops or po) or one of its excipients
- History of an injection poorly tolerated fluorescein
- A history of food allergy or drug known
- Myocardial infarction <1 month
- Unstable angina
- Pregnant or lactating woman, premenopausal women without adequate contraception
- Person under guardianship
- Patient participating in another trial / participating in another trial within 4 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: patients with a suspicion of emphysema
A bronchoscopy with in vivo confocal endomicroscopy is assessed for patient with a suspicion of emphysema
|
A bronchoscopy with in vivo confocal endomicroscopy is done for patients with a suspicion of emphysema or for patients with a suspicion of scleroderma
|
|
Experimental: patients with a suspicion of scleroderma
A bronchoscopy with in vivo confocal endomicroscopy is assessed for patient with a suspicion of sclerodermia
|
A bronchoscopy with in vivo confocal endomicroscopy is done for patients with a suspicion of emphysema or for patients with a suspicion of scleroderma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of extra-alveolar diameter of capillaries of patient with pulmonary emphysema or pulmonary scleroderma
Time Frame: Day 1
|
Extra-alveolar diameter of capillaries is assessed using in vivo confocal endomicroscopy
|
Day 1
|
|
Measurement of intercapillary distance of patient with pulmonary emphysema or pulmonary scleroderma
Time Frame: Day 1
|
Intercapillary distance is assessed using in vivo confocal endomicroscopy
|
Day 1
|
|
Measurement of length of the capillary portions of patient with pulmonary emphysema or pulmonary scleroderma
Time Frame: Day 1
|
Length of the capillary is assessed using in vivo confocal endomicroscopy
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of alveolar diameter entries of patient with pulmonary emphysema or pulmonary scleroderma
Time Frame: Day 1
|
Alveolar diameter entries is assessed using in vivo confocal endomicroscopy
|
Day 1
|
|
Measurement of axial thickness of elastic fibers of patient with pulmonary emphysema or pulmonary scleroderma
Time Frame: Day 1
|
Axial thickness of elastic fibers is assessed using in vivo confocal endomicroscopy
|
Day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mathieu SALAUN, MD, University Hospital, Rouen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Respiratory Tract Diseases
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Pathological Conditions, Signs and Symptoms
- Lung Diseases
- Pulmonary Emphysema
- Diagnostic Techniques and Procedures
- Diagnosis
- Surgical Procedures, Operative
- Minimally Invasive Surgical Procedures
- Diagnostic Techniques, Surgical
- Endoscopy
- Diagnostic Techniques, Respiratory System
- Thoracic Surgical Procedures
- Pulmonary Surgical Procedures
- Bronchoscopy
Other Study ID Numbers
- 2013/093/HP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Emphysema
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Beijing Municipal Science & Technology CommissionUnknownCombined Pulmonary Fibrosis and EmphysemaChina
-
Pulmonx CorporationRecruitingEmphysema or COPD | Emphysema, PulmonaryUnited States, Australia, Austria, Denmark, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Asan Medical CenterUnknownPulmonary Disease, Chronic Obstructive | Microbiota | Emphysema or COPDKorea, Republic of
-
Aarhus University HospitalRecruitingChronic Obstructive Pulmonary Disease | Emphysema or COPDDenmark
-
IHF GmbH - Institut für HerzinfarktforschungRecruitingEmphysema or Chronic Obstructive Pulmonary DiseaseGermany
-
IRCCS Azienda Ospedaliera Universitaria San Martino...CompletedInterstitial Pulmonary Fibrosis, EmphysemaItaly
-
Heidelberg UniversityUnknown
-
Royal Brompton & Harefield NHS Foundation TrustCompletedHeterogeneous EmphysemaUnited Kingdom
-
Aeris TherapeuticsCompleted
Clinical Trials on Bronchoscopy with in vivo confocal endomicroscopy
-
Amsterdam University Medical Centers (UMC), Location...Mauna Kea TechnologiesRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Lung Neoplasm Malignant | Neoplasm of LungUnited States, Greece, Czechia, Netherlands, Austria
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Active, not recruitingLung Cancer | Lung Neoplasm | Peripheral Lung Parenchyma TumorNetherlands
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)CompletedMelanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-Malignant Skin DisordersUnited States
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)TerminatedCervical Cancer | Precancerous ConditionCanada
-
Tufts Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS)SuspendedDry Eye Syndromes | Corneal DiseaseUnited States
-
Tufts Medical CenterCompleted
-
Sorlandet Hospital HFRecruiting
-
Hospices Civils de LyonTerminatedLow Grade Glioma (LGG), High Grade Glioma (HGG)France
-
China-Japan Friendship HospitalNot yet recruitingSolitary Pulmonary Nodule | Multiple Pulmonary Nodule
-
Mayo ClinicWithdrawn